glp-1 sglt2 combination Receptor Agonists and Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs Frontiers | Mechanisms of action

CrossRef A Newly Synbiotic Combination Alleviates Obesity by Modulating the Gut MicrobiotaFat Axis and Inhibiting the Hepatic TLR4/NFB Signaling Pathway Yongbo Kang, Peng Ren, Xiaorong Shen, Xiaoyu Kuang, Xiaodan Yang, Haixia Liu, Huan Yan, Hao Yang, Xing Kang, Zeyuan Ding, Xuguang Luo, Jieqiong Ma, Ying Yang, Weiping Fan Molecular Nutrition & Food Research.2023;[Epub] CrossRef Lacticaseibacillus paracasei AO356 ameliorates obesity by regulating adipogenesis and thermogenesis in C57BL/6J male mice Young In Kim, Eun-Sook Lee, Eun-Ji Song, Dong-Uk Shin, Ji-Eun Eom, Hee Soon Shin, Jung Eun Kim, Ju Yeoun Oh, Young-Do Nam, So-Young Lee Journal of Functional Foods.2023

Acknowledgements We thank Christopher Rhodes, PhD, for his expert review of the manuscript and helpful discussions

doi:10.1055/s-0035-1548790

People who are switching between medications benefit because the transition period involves two overlapping decay curves

Another study was conducted similarly in both obese and lean mice

Beware of external links.